Xiaoyun has over 22 years of experience in the biotechnology industry. He has founded several companies in antibody production and engineering (ADV Biologics Inc and Amesino LLC). He co-founded Tranzyme Pharma (NASDAQ: TZYM). Prior to joining industry, he served as a Principal Investigator at the University of Alabama at Birmingham School of Medicine and co-authored over 20 peer-reviewed papers.
Dr. Wakefield has more than 22 years of biotechnology and biopharmaceutical research employment, which includes Director, Gene Delivery & Applied Genomics, Tranzyme Pharma Inc., and Senior Scientist at Thermo Scientific/Open Biosystems. He founded Verified Biosystems LLC, in 2015, which is a contract research company providing expertise in delivery and expression of genetic content and development of cell-based assays.
In 2018, Ellen received her B.S.B.A in healthcare management from Washington University. She published her undergraduate research in a peer-reviewed journal and has been the recipient of several research fellowships, including the Fulbright and the DAAD Research Grant for doctoral candidates and young academics and scientists.